Tandem Diabetes Care (TNDM) Interest & Investment Income (2013 - 2025)
Tandem Diabetes Care posted quarterly Interest & Investment Income of $4.2 million for Q1 2025, down 21.1% year-on-year from $5.3 million in Q1 2024, and down 7.05% on a QoQ basis from $4.5 million in Q4 2024.
Tandem Diabetes Care (TNDM) has 13 years of Interest & Investment Income data on file, last reported at $4.2 million in Q1 2025.
- For the quarter ending Q1 2025, Interest & Investment Income fell 21.1% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2025 stood at $16.9 million (down 24.36% YoY), and the FY2024 full-year result was $18.0 million, down 21.28% from the prior year.
- Interest & Investment Income for Q1 2025 stood at $4.2 million, down from $4.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.9 million in Q1 2023 and bottomed at -$47000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $3.1 million (2022), against an average of $3.0 million.
- The widest annual swing landed in 2021, when Interest & Investment Income tumbled 114.16%; it then jumped 6687.23% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at -$47000.0 in 2021, then surged by 6687.23% to $3.1 million in 2022, then soared by 79.36% to $5.6 million in 2023, then dropped by 18.76% to $4.5 million in 2024, then dropped by 7.05% to $4.2 million in 2025.
- The last three Interest & Investment Income figures came in at $4.2 million (Q1 2025), $4.5 million (Q4 2024), and $5.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 5.34 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 5.87 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 826,000.00 |
| Mar 31, 2022 | 415,000.00 |
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 418,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 143,000.00 |
| Jun 30, 2020 | 367,000.00 |
| Mar 31, 2020 | 726,000.00 |
| Dec 31, 2019 | 812,000.00 |
| Sep 30, 2019 | 854,000.00 |
| Jun 30, 2019 | 786,000.00 |
| Mar 31, 2019 | 757,000.00 |
| Dec 31, 2018 | 606,000.00 |
| Sep 30, 2018 | 443,000.00 |
| Jun 30, 2018 | 299,000.00 |
| Mar 31, 2018 | 91,000.00 |
| Dec 31, 2017 | 60,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 60,000.00 |
| Mar 31, 2017 | 59,000.00 |
| Dec 31, 2016 | 38,000.00 |
| Sep 30, 2016 | 34,000.00 |
| Jun 30, 2016 | 107,000.00 |
| Mar 31, 2016 | 118,000.00 |
| Dec 31, 2015 | 90,000.00 |
| Sep 30, 2015 | 87,000.00 |
| Jun 30, 2015 | 61,000.00 |
| Mar 31, 2015 | 99,000.00 |
| Dec 31, 2014 | 33,000.00 |
| Sep 30, 2014 | 30,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | 18,000.00 |
| Dec 31, 2013 | 6,389.00 |
| Sep 30, 2013 | 151.00 |
| Jun 30, 2013 | 234.00 |
| Mar 31, 2013 | 226.00 |